Farrar Cyclone Forced Air Ultra-Low Freezer for the Department of Transfusion Medicine
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 26-006077 in this department, oldest first.
- Aug 6, 2026Pre-solicitationOpen
- Aug 6, 2026 · this noticePre-solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Title: Farrar Cyclone Forced Air Ultra-Low Freezer for the Department of Transfusion Medicine Notice ID (POTS): 26-006077 Product Service Code (PSC): 4110 � Refrigeration Equipment NAICS Code: 333415 � Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing Place of Performance: National Institutes of Health Clinical Center Department of Transfusion Medicine Bethesda, MD 20892 Notice The National Institutes of Health (NIH), Clinical Center, Office of Purchasing and Contracts, intends to award a sole-source firm-fixed-price purchase or… (show all)
der to Helmer for the procurement of a Farrar Cyclone Forced Air Ultra-Low Freezer, including delivery, setup, and a service plan, for use by the Department of Transfusion Medicine. The freezer will be used to store supplies, reagents, and blood products that support patient care at the NIH Clinical Center. Requirement The Department of Transfusion Medicine requires a high-quality ultra-low temperature freezer that meets all applicable regulatory and licensing requirements for the storage of critical laboratory supplies, reagents, and blood products used in patient care. The procurement includes: Farrar Cyclone Forced Air Ultra-Low Freezer, Model FCF133 (33 cu. ft.) Delivery and installation Manufacturer service plan Sole-Source Rationale The Department of Transfusion Medicine supports patient care and clinical research by maintaining regulated storage conditions for blood products and laboratory reagents. Helmer is an industry leader in transfusion medicine storage equipment, and its equipment meets the Department's regulatory and licensing requirements. The Government determined that Helmer is the only source reasonably available to satisfy the agency's requirements for this acquisition. Authority This acquisition is being conducted in accordance with FAR 13.106-1(b)(1)(i), which permits contracting officers to solicit from a single source for acquisitions not exceeding the Simplified Acquisition Threshold when only one source is reasonably available. Capability Statements This notice is not a request for competitive quotations or proposals. Responsible sources that believe they are capable of satisfying the Government's requirement may submit a capability statement demonstrating their ability to provide an equivalent product meeting all technical, regulatory, and performance requirements. The Government will evaluate all timely capability statements solely for the purpose of determining whether to conduct a competitive procurement. Submission Instructions Capability statements shall reference POTS No. 26-006077 and must be submitted electronically no later than August 13, 2026, at 6:00 p.m. Eastern Time (ET). Point of Contact Shasheshe Goolsby Team Leader Hospital and Laboratory Support Division Office of Acquisitions and Logistics Management National Institutes of Health Email: shasheshe.goolsby@nih.gov
Recent Agency Awards (Loose Match)
258 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
Single-winner award sizes (181): middle half $90K to $17.1M, median $750K; range $12K to $89.0B.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BECTON, DICKINSON AND COMPANY · $BDX · $22.5B | 4 | $1.9M | Jan 26, 2026 |
| DUKE UNIVERSITY Durham NC 27705 USA | 3 | $36.3M + 1 shared | Dec 21, 2025 |
| Axle Informatics Rockville MD 20852 USA | 3 | $24.5M | May 22, 2025 |
| Axle Informatics, LLC | 3 | $15.4M | Dec 15, 2025 |
| BRUKER BIOSPIN CORP · $BRKR · $3.5B | 3 | $1.7M | Jul 30, 2026 |
| AGILENT TECHNOLOGIES INC · $A · $7.4B | 3 | $445K | Jul 24, 2025 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 3 | $318K | Jan 9, 2026 |
| Multiple_Awards Bethesda MD USA | 2 | $1.1B | Dec 17, 2024 |
| FISHER BIOSERVICES INC | 2 | $100.0M + 1 shared | Oct 7, 2026 |
| Coriell Institute for Medical Research, Inc. | 2 | $58.8M | Aug 1, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $BDX reported $22.5B revenue (12 months to Jun 30, 2026). The median single-winner award in these 181 past awards, $750K, is under 0.1% of that. SEC filing
- $BRKR reported $3.5B revenue (12 months to Jun 30, 2026). The median single-winner award in these 181 past awards, $750K, is under 0.1% of that. SEC filing
- $A reported $7.4B revenue (12 months to Jul 31, 2026). The median single-winner award in these 181 past awards, $750K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 9, 2026Revvity Health Sciences, Inc.$21KAutomated Cell Counter and AnalyzerNo listed company matched (Materiality N/A)
- Oct 7, 2026BCG FEDERAL CORP.$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Oct 7, 2026SIA PARTNERS U.S., INC.$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Oct 7, 2026FISHER BIOSERVICES INC$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Oct 7, 2026ADVANCED BIOSCIENCE LABORATORIES, INC.$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Oct 7, 2026PPD DEVELOPMENT LP$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Oct 7, 2026AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Sep 30, 2026Washington Metropolitan Area Transit Authority Washington DC 20024 USA$23.8MNIH TRANShare Program -WMATA SmartBenefits� Program Transit Benefit ServicesNo listed company matched (Materiality N/A)
- Sep 29, 2026THE BROAD INSTITUTE, INC$215KWhole genome sequencing for investigation of age-related chronic disease in HANDLS participantsNo listed company matched (Materiality N/A)
- Sep 28, 2026EMORY UNIVERSITY 1599 CLIFTON ROAD NE 4TH FLOOR MAILSTOP 1599-001-1BA Atlanta GA 30322 USA$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation StudyShared multiple-award ceiling, not one company's win (Materiality N/A)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- $45K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 3 of the past winners are listed companies
- 0 insider buys and 5 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.